Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children

NCT06530004 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.

NCT NCT06530004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06530004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children
Lead sponsor
The First Affiliated Hospital of Xiamen University
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2020
Completion date
March 1, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, efficacy, nephrotic syndrome, rituximab